Newsletter

068760 - Celltrion Pharm, Inc.

068760 Summary
Biopharma
Stock Price & Overview
₩40,850 +0 (+0.00%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩40,850  ≈ US$29  ·  Market cap ₩1.8tn (≈ $1.3bn)
Home › 068760 › Filings

Future business and management plan (fair disclosure)

DART
Celltrion Pharm, Inc.
Filed Jul 2, 2026 KST · Filing · receipt 20260702900216

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 장래사업ㆍ경영계획(공정공시)

068760

Price
₩40,850
Change
+0.00%
Market cap
₩1.8tn
Prev. close
₩40,850
068760 SummaryCompare to Peers

More 068760 filings

Large business group status disclosure — quarterly, individual company

08/27/26

Half-Year Report

08/14/26

Supplier Payment Terms and Dispute-Resolution Disclosure

08/14/26

Preliminary operating results (fair disclosure)

08/04/26

Large business group status disclosure — annual and Q1, individual company

06/01/26

Quarterly Report

05/15/26